Miami researchers discover process to sustainably produce psilocybin using genetically engineered E Coli bacteria. Psilocybin is now in clinical trials, and medical professionals see promising results for its use in treating addiction, depression and post-traumatic stress disorder in humans.

submitted by /u/mvea [link] [comments]

Vaccine campaign for world's largest measles outbreak - More than 800,000 children are to be targeted for vaccination in the Democratic Republic of Congo in slightly more than a week, after a measles outbreak killed more than 3,500 people this year.

submitted by /u/mvea [link] [comments]

In Tiny Doses, An Addiction Medication Moonlights As Treatment For Chronic Pain: ...there’s been a significant increase in new studies published on low-dose naltrexone, many strengthening claims of its effectiveness as a treatment for chronic pain, though most of these were small pilot studies

submitted by /u/shallah [link] [comments]

No vaping ban U-turn, says Indian official, as protests fizzle

No vaping ban U-turn, says Indian official, as protests fizzle
Reuters: Health
India's government has no plan to roll back a ban on electronic cigarettes, an official told Reuters on Saturday, as protests against the move by vapers in six cities drew scant support.

The gut microbiome of mammals program the metabolic rhythms that govern absorption of dietary fat with the day-night cycle, suggests new study in mice, and disrupting this with antibiotics or working overnight may make us obese, but findings may lead to new treatments for obesity or malnutrition.

submitted by /u/mvea [link] [comments]

U.S. travel warning adds to pressure on Tanzania over suspected Ebola cases

U.S. travel warning adds to pressure on Tanzania over suspected Ebola cases
Reuters: Health
The United States has warned its citizens to take extra care when visiting Tanzania amid concerns over Ebola, adding to calls for the East African country to share information about suspected cases of the deadly disease there.

Low response rate reported for Amgen targeted drug in colon cancer trial

Low response rate reported for Amgen targeted drug in colon cancer trial
Reuters: Health
An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12 patients with advanced colorectal cancer who were given the highest dose in a small, early-stage trial, the company said on Saturday.